﻿<?xml version="1.0" encoding="UTF-8"?>
<!--RSS generated by Microsoft SharePoint Foundation RSS Generator on 5/19/2013 12:59:51 PM -->
<?xml-stylesheet type="text/xsl" href="/en/events/_layouts/RssXslt.aspx?List=da5fe6e0-3b5b-420d-801a-a7cdea8631cd" version="1.0"?>
<rss version="2.0">
  <channel>
    <title>News &amp; Events: West Podcasts</title>
    <link>http://www.westpharma.com/en/events/West Podcasts/Forms/AllItems.aspx</link>
    <description>RSS feed for the West Podcasts list.</description>
    <lastBuildDate>Sun, 19 May 2013 16:59:51 GMT</lastBuildDate>
    <generator>Microsoft SharePoint Foundation RSS Generator</generator>
    <ttl>60</ttl>
    <language>en-US</language>
    <image>
      <title>News &amp; Events: West Podcasts</title>
      <url>http://www.westpharma.com/en/events/_layouts/images/homepage.gif</url>
      <link>http://www.westpharma.com/en/events/West Podcasts/Forms/AllItems.aspx</link>
    </image>
    <item>
      <title>Auto-Injector Systems for Injectable Drug Administration</title>
      <link>http://www.westpharma.com/en/events/West Podcasts/Auto-Injector Systems for Injectable Drug Administration.mp3</link>
      <description><![CDATA[More and more, pharmaceutical and biopharmaceutical companies are emphasizing combination products as drug developers recognize the value of adding a delivery system to their drug. As this trend develops, pharmaceutical companies are turning to resources that can help them understand combination products, especially the interdependence between a prefillable syringe and an auto-injector. 
&lt;br&gt;&lt;br&gt;
West’s Glenn Thorpe discusses the ConfiDose® auto-injector system as well as his views on where the industry is heading in the next three to five years, and the future of delivery systems.]]></description>
      <author>Greg Robinson</author>
      <enclosure url="http://www.westpharma.com/en/events/West Podcasts/Auto-Injector Systems for Injectable Drug Administration.mp3" type="" />
      <pubDate>Fri, 03 Dec 2010 20:54:23 GMT</pubDate>
      <guid isPermaLink="true">http://www.westpharma.com/en/events/West Podcasts/Auto-Injector Systems for Injectable Drug Administration.mp3</guid>
    </item>
    <item>
      <title>Biologic Drug Products and the Need for Subcutaneous Delivery</title>
      <link>http://www.westpharma.com/en/events/West Podcasts/Biologic Drug Products and the Need for Subcutaneous Delivery.mp3</link>
      <description><![CDATA[Growth in injectable therapies has resulted in an increasing number of new biologic drug products. Treatment regimens for these products can be complex, and often fall directly to the patient or a caregiver rather than a trained clinician. As the trend toward self-injection grows, auto-injection systems and devices are evolving to suit patient needs for subcutaneous delivery. Listen to Bart Burgess as he discusses how biologic drug products are affecting the market and the developments that can aid patients who require these drugs.]]></description>
      <author>Gleason, Deirdre</author>
      <enclosure url="http://www.westpharma.com/en/events/West Podcasts/Biologic Drug Products and the Need for Subcutaneous Delivery.mp3" type="" />
      <pubDate>Fri, 09 Dec 2011 15:26:51 GMT</pubDate>
      <guid isPermaLink="true">http://www.westpharma.com/en/events/West Podcasts/Biologic Drug Products and the Need for Subcutaneous Delivery.mp3</guid>
    </item>
    <item>
      <title>Glass Delamination</title>
      <link>http://www.westpharma.com/en/events/West Podcasts/Glass Delamination.mp3</link>
      <description><![CDATA[Recent drug product recalls have been caused by issues associated with glass, including breakage, delamination and particulate formation.  These issues could adversely affect the health of patients and create a serious financial burden on the drug manufacturer. Join West’s Gene Polini as he discusses general glass vial manufacturing processes and the chemical reactions that can lead to problems such as delamination.]]></description>
      <author>Sutcliffe, Kathleen</author>
      <enclosure url="http://www.westpharma.com/en/events/West Podcasts/Glass Delamination.mp3" type="" />
      <pubDate>Tue, 14 Dec 2010 17:47:15 GMT</pubDate>
      <guid isPermaLink="true">http://www.westpharma.com/en/events/West Podcasts/Glass Delamination.mp3</guid>
    </item>
    <item>
      <title>Knowledge Management</title>
      <link>http://www.westpharma.com/en/events/West Podcasts/Knowledge Management.mp3</link>
      <description><![CDATA[Knowledge management is a range of strategies and practices that can help identify, create and distribute the insight and experience of a company.  Listen to West’s Fran DeGrazio, Vice President – Marketing &amp; Strategic Development, as she discusses West’s knowledge management strategies and how those practices can aid our customers.]]></description>
      <author>Sutcliffe, Kathleen</author>
      <enclosure url="http://www.westpharma.com/en/events/West Podcasts/Knowledge Management.mp3" type="" />
      <pubDate>Fri, 29 Apr 2011 15:43:41 GMT</pubDate>
      <guid isPermaLink="true">http://www.westpharma.com/en/events/West Podcasts/Knowledge Management.mp3</guid>
    </item>
    <item>
      <title>Reducing Overfill for High-Value Drugs</title>
      <link>http://www.westpharma.com/en/events/West Podcasts/Reducing Overfill for High-Value Drugs.mp3</link>
      <description><![CDATA[Innovations in the drug delivery market include unique administration systems, such as West’s Vial Adapters, that not only provide the opportunity for needle-free transfer of liquid for reconstituting lyophilized drug products, but also a means for consistent withdrawal of drug product from a drug vial.
&lt;br&gt;&lt;br&gt;
In this podcast, West’s Glen Zimmermann, Associate Marketing Director, Safety and Administration Systems, discusses reducing overfill through the use of vial adapters.]]></description>
      <author>Greg Robinson</author>
      <enclosure url="http://www.westpharma.com/en/events/West Podcasts/Reducing Overfill for High-Value Drugs.mp3" type="" />
      <pubDate>Fri, 03 Dec 2010 20:54:51 GMT</pubDate>
      <guid isPermaLink="true">http://www.westpharma.com/en/events/West Podcasts/Reducing Overfill for High-Value Drugs.mp3</guid>
    </item>
    <item>
      <title>The Potential Impact of Revised cGMPs</title>
      <link>http://www.westpharma.com/en/events/West Podcasts/The Potential Impact of Revised cGMPs.mp3</link>
      <description><![CDATA[The Food and Drug Administration has amended current Good Manufacturing Practice requirements for finished pharmaceuticals (21 CFR Parts 210 &amp; 211) using a phased, incremental approach. The amendment was effective December 8, 2008. 
&lt;br&gt;&lt;br&gt;
In this podcast, Debbie Thomas, West’s Vice President of Regulatory Affairs, discusses the potential impact to the preparation of components for sterile drug products.  ]]></description>
      <author>Greg Robinson</author>
      <enclosure url="http://www.westpharma.com/en/events/West Podcasts/The Potential Impact of Revised cGMPs.mp3" type="" />
      <pubDate>Fri, 03 Dec 2010 20:56:01 GMT</pubDate>
      <guid isPermaLink="true">http://www.westpharma.com/en/events/West Podcasts/The Potential Impact of Revised cGMPs.mp3</guid>
    </item>
  </channel>
</rss>